SIGA Technologies
SIGA
#7361
Rank
A$0.67 B
Marketcap
A$9.38
Share price
-2.21%
Change (1 day)
0.22%
Change (1 year)

SIGA Technologies (SIGA) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : A$42.57 Million

According to SIGA Technologies's latest financial reports the company's total liabilities are A$42.57 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

SIGA Technologies - Total liabilities on balance sheet (from 2001 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31A$45.87 M-45.64%
2023-12-31A$84.38 M130.85%
2022-12-31A$36.55 M-34.42%
2021-12-31A$55.74 M113.9%
2020-12-31A$26.05 M-81.9%
2019-12-31A$0.14 B0.87%
2018-12-31A$0.14 B-76.19%
2017-12-31A$0.59 B-3.67%
2016-12-31A$0.62 B-3.61%
2015-12-31A$0.64 B29.7%
2014-12-31A$0.49 B150.98%
2013-12-31A$0.19 B165.53%
2012-12-31A$74.66 M54.32%
2011-12-31A$48.38 M228.45%
2010-12-31A$14.73 M-29.47%
2009-12-31A$20.88 M103.46%
2008-12-31A$10.26 M67.43%
2007-12-31A$6.13 M-28.35%
2006-12-31A$8.55 M117.87%
2005-12-31A$3.92 M95.93%
2004-12-31A$2 M171.8%
2003-12-31A$0.73 M-36.74%
2002-12-31A$1.16 M-10.68%
2001-12-31A$1.3 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Emergent BioSolutions
EBS
A$1.32 B 3,023.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
A$75.79 M 78.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
A$2.02 B 4,652.35%๐Ÿ‡บ๐Ÿ‡ธ USA
NanoViricides
NNVC
A$1.97 M-95.35%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
A$1.26 B 2,866.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
A$3.28 B 7,627.58%๐Ÿ‡บ๐Ÿ‡ธ USA